Výsledky vyhledávání - "Jessie L. Fahrbach"

Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme

Autor: Kathleen Dungan, Itamar Raz, Jessie L. Fahrbach, Whitney Sealls, Zachary Skrivanek

Publikováno v: Diabetes, Obesity & Metabolism

Aim To compare the effectiveness of dulaglutide 1.5 and 0.75 mg with active comparators and placebo with regard to a composite endpoint of glycated haemoglobin (HbA1c), weight and hypoglycaemia, using post hoc analyses. Methods A logistic regression

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f2c16a49bfc9c50782c8998de81c14
https://doi.org/10.1111/dom.12575

Zobrazit plný text záznamu

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

Autor: Lawrence Blonde, Honghua Jiang, Jessie L. Fahrbach, Zvonko Milicevic, Jorge Luiz Gross, Vincent Woo, Johan Jendle

Publikováno v: The Lancet. 385:2057-2066

For patients with type 2 diabetes who do not achieve target glycaemic control with conventional insulin treatment, advancing to a basal-bolus insulin regimen is often recommended. We aimed to compare the efficacy and safety of long-acting glucagon-li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9ae694e7f70fa658ac922998e28665
https://doi.org/10.1016/s0140-6736(15)60936-9

Zobrazit plný text záznamu

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial

Autor: Stephen Hippler, John B. Buse, Sherry Martin, Honghua H. Jiang, Sylvia K. Shenouda, William H. Herman, Bruce H. R. Wolffenbuttel, Jessie L. Fahrbach

Publikováno v: Diabetes Care. 34:249-255

OBJECTIVE This study compared the durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25: 75% insulin lispro protamine suspension/25% lispro) and once-daily insulin glargine, added to oral antihyperglycemic drugs in type 2 di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::891de63bf43b06dcb105a691888e6d90
https://doi.org/10.2337/dc10-1701

Zobrazit plný text záznamu

Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial

Autor: Lauren Nelson, Lauren J. Lee, Jessie L. Fahrbach, Lori McLeod, Peter Sun, Sherry Martin, Ruth S. Weinstock

Publikováno v: Diabetes Research and Clinical Practice. 89:157-166

To examine changes in patient-reported outcome (PRO) measures in patients with type 2 diabetes (T2DM) on oral agents who initiated insulin (insulin lispro mix 25/75 [LM25] or insulin glargine) in the DURABLE trial (n=580).Subjects completed generic a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ff075441784a3aaec41aa09deb431b
https://doi.org/10.1016/j.diabres.2010.04.002

Zobrazit plný text záznamu

Initiating insulin therapy in elderly patients with Type 2 diabetes

Autor: Jessie L. Fahrbach, Sherry Martin, H. Jiang, Bruce H. R. Wolffenbuttel, R. Bhushan, L. J. Klaff

Publikováno v: Diabetic Medicine, 26(11), 1147-1155. Wiley

AimsTo compare starter insulins in the elderly subgroup of the DURABLE trial 24-week initiation phase.MethodsIn a post-hoc analysis of the >= 65 years subgroup enrolled in the DURABLE trial, we compared the safety and efficacy of lispro mix 25 (LM25:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0964b9fda7e3d7ee146feb5ddc576fa9
https://doi.org/10.1111/j.1464-5491.2009.02824.x

Zobrazit plný text záznamu

Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes

Autor: Jessie L. Fahrbach, Sherry Martin, Bruce H. R. Wolffenbuttel, Honghua Jiang, Kathleen Dungan, John B. Buse, William H. Herman

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 94(5), 1689-1694. ENDOCRINE SOC

Content: Recent studies have reported hemoglobin A(1c) (A1c) differences across racial/ethnic groups. Our diverse population allows for further investigation of potential differences in measurements of glycemia.Objectives: Our objectives were to desc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338306fe21c642519d5905a18e7384a2
https://doi.org/10.1210/jc.2008-1940

Zobrazit plný text záznamu

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results

Autor: Sherry Martin, William H. Herman, Bruce H. R. Wolffenbuttel, Jessie L. Fahrbach, Natalie K. Shemonsky, John B. Buse, Honghua H. Jiang, Jamie Scism-Bacon

Publikováno v: Diabetes Care. 32:1007-1013

OBJECTIVE To compare the ability of two starter insulin regimens to achieve glycemic control in a large, ethnically diverse population with type 2 diabetes. RESEARCH DESIGN AND METHODS During the initiation phase of the DURABLE trial, patients were r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d92b7e757d3c5b342449e9f150a3e86c
https://doi.org/10.2337/dc08-2117

Zobrazit plný text záznamu

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

Autor: José G. González, Jessie L. Fahrbach, Santiago Tofe Povedano, Kathleen Dungan, Thomas Forst, Whitney Sealls, Charles Atisso

Publikováno v: Lancet (London, England). 384(9951)

Dulaglutide and liraglutide, both glucagon-like peptide-1 (GLP-1) receptor agonists, improve glycaemic control and reduce weight in patients with type 2 diabetes. In a head-to-head trial, we compared the safety and efficacy of once-weekly dulaglutide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7d3104a76bb4be202a5368def889bd
https://pubmed.ncbi.nlm.nih.gov/25402542

Zobrazit plný text záznamu

Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization

Autor: Şerban R. Iorga, Ying Fan, Jessie L. Fahrbach, Shonda A. Foster, Richard M. Bergenstal

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 18(3)

OBJECTIVE To evaluate treatment patterns associated with diabetes medication regimen changes after hospitalization on the basis on preadmission hemoglobin A1c levels. METHODS In this retrospective database analysis, patients with a diabetes diagnosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1263fba9aa51570a54747c96b9c608
https://pubmed.ncbi.nlm.nih.gov/22548941

Zobrazit plný text záznamu

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus

Autor: Henry Rodriguez, Kevin Kaiserman, Linda Wolka, Jessie L. Fahrbach, Amanda Stephenson

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 18(3)

Objective To provide a comprehensive review of insulin lispro administered by continuous subcutaneous insulin infusion (CSII) in children and adolescents. Methods We performed PubMed literature searches to identify clinical studies of insulin lispro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef0509da629b6cb988a07b2e659ef5b
https://pubmed.ncbi.nlm.nih.gov/22297055

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání